• 1. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 4. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 5. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Linear 1,3-diarylpropanoids Retro-dihydrochalcones
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Linear 1,3-diarylpropanoids Chalcones and dihydrochalcones Retro-dihydrochalcones

Recent Advances in the Study of 3',5'-Dimethyl-3-(2-methylphenyl)propiophenone (CAS: 898789-60-1)

In recent years, the compound 3',5'-Dimethyl-3-(2-methylphenyl)propiophenone (CAS: 898789-60-1) has garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique structural features, has shown promising potential in various therapeutic applications. The latest studies have focused on elucidating its pharmacological properties, synthetic pathways, and potential mechanisms of action, making it a subject of intense scientific inquiry.

One of the key areas of research has been the synthesis and optimization of 3',5'-Dimethyl-3-(2-methylphenyl)propiophenone. Recent publications have highlighted novel synthetic routes that improve yield and purity, which are critical for scaling up production for preclinical and clinical studies. Advanced techniques such as microwave-assisted synthesis and catalytic asymmetric synthesis have been employed to enhance the efficiency and stereoselectivity of the process. These advancements are expected to facilitate further exploration of the compound's biological activities.

Pharmacological studies have revealed that 3',5'-Dimethyl-3-(2-methylphenyl)propiophenone exhibits notable activity in modulating specific biological pathways. For instance, preliminary in vitro and in vivo experiments suggest its potential as an anti-inflammatory agent, with mechanisms involving the inhibition of key pro-inflammatory cytokines. Additionally, its interaction with certain enzyme targets has sparked interest in its application for neurodegenerative diseases, where modulation of enzymatic activity could offer therapeutic benefits.

Another significant development is the exploration of the compound's pharmacokinetic and toxicological profiles. Recent findings indicate favorable absorption and distribution properties, although further studies are needed to fully understand its metabolism and excretion. Toxicological assessments have shown a relatively safe profile at therapeutic doses, but long-term studies are required to confirm its safety for human use. These insights are crucial for advancing the compound through the drug development pipeline.

In conclusion, the ongoing research on 3',5'-Dimethyl-3-(2-methylphenyl)propiophenone (CAS: 898789-60-1) underscores its potential as a versatile therapeutic agent. The advancements in synthesis, coupled with its promising pharmacological properties, position this compound as a valuable candidate for further investigation. Future studies should focus on elucidating its mechanisms of action, optimizing its therapeutic efficacy, and addressing any potential safety concerns to pave the way for clinical applications.

• 898794-78-0(3-(2,5-Dimethylphenyl)-4'-methylpropiophenone)
• 898768-98-4(3-(2,3-Dimethylphenyl)-3'-methylpropiophenone)
• 898793-57-2(3-(2,4-Dimethylphenyl)-4'-methylpropiophenone)
• 898793-55-0(3-(2,4-Dimethylphenyl)-3'-methylpropiophenone)
• 52086-46-1(5(6H)-Benzocyclodecenone, 7,8,9,10,11,12-hexahydro-4-methyl-)
• 52086-36-9(5(6H)-Benzocyclooctenone, 7,8,9,10-tetrahydro-4-methyl-)
• 898769-00-1(3-(2,3-Dimethylphenyl)-4'-methylpropiophenone)
• 898754-28-4(3-(2,6-Dimethylphenyl)-3'-methylpropiophenone)
• 898794-76-8(3-(2,5-Dimethylphenyl)-3'-methylpropiophenone)
• 898754-30-8(3-(2,6-Dimethylphenyl)-4'-methylpropiophenone)